These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 10256911)

  • 21. [How do pharmacists evaluate the newly introduced system of substituting prescriptions?].
    Rubak SL; Andersen ML; Mainz J; Olesgaard P; Laursen K; Schaumann M; Lauritzen T
    Ugeskr Laeger; 2000 Nov; 162(45):6074-7. PubMed ID: 11107945
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Attitudes of pharmacists and physicians toward Florida's drug product selection law.
    Vuturo GJ; McCormick WC; Krischer JP
    Contemp Pharm Pract; 1980; 3(3):156-62. PubMed ID: 10247871
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Generic drugs].
    Lemye R
    Rev Med Brux; 2000 Sep; 21(4):A273-5. PubMed ID: 11068479
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Ohio Generic Product Selection Law: influence on pharmacy practice.
    Hunter RH
    Med Mark Media; 1979 Jul; 14(7):33-6. PubMed ID: 10243269
    [No Abstract]   [Full Text] [Related]  

  • 25. The importance of bioavailability to the pharmacist.
    Canada AT
    Int J Clin Pharmacol Biopharm; 1975 Jun; 11(4):346-8. PubMed ID: 1158541
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A study on rational drug prescribing and dispensing in outpatients in a tertiary care teaching hospital of Western Nepal.
    Alam K; Mishra P; Prabhu M; Shankar PR; Palaian S; Bhandari RB; Bista D
    Kathmandu Univ Med J (KUMJ); 2006; 4(4):436-43. PubMed ID: 18603950
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Generic substitution laws--physicians' liability.
    Trout ME
    J Leg Med (N Y); 1977 Jul; 5(7):14-6. PubMed ID: 301915
    [No Abstract]   [Full Text] [Related]  

  • 28. Impact of education by clinical pharmacists on physician ambulatory care prescribing of generic versus brand-name drugs.
    Erramouspe J
    DICP; 1989 Oct; 23(10):770-3. PubMed ID: 2815852
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Financial incentives and physicians' prescription decisions on the choice between brand-name and generic drugs: evidence from Taiwan.
    Liu YM; Yang YH; Hsieh CR
    J Health Econ; 2009 Mar; 28(2):341-9. PubMed ID: 19091433
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug product selection legislation: a comparative analysis.
    Wetherbee H; Sharpe TR
    Am J Pharm Sci Support Public Health; 1978; 150(6):171-6. PubMed ID: 576098
    [No Abstract]   [Full Text] [Related]  

  • 31. [Physicians' expectations towards pharmacy services on ward].
    Bourget S; Allenet B; Bedouch P; Bosson LJ; Calop J
    J Pharm Belg; 2007; 62(4):130-4. PubMed ID: 18269141
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Do the incentives in 3-tier pharmaceutical benefit plans operate as intended? Results from a physician leadership survey.
    Shrank WH; Young HN; Ettner SL; Glassman P; Asch SM; Kravitz RL
    Am J Manag Care; 2005 Jan; 11(1):16-22. PubMed ID: 15697096
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Generic substitution of antihypertensive drugs: does it affect adherence?
    Van Wijk BL; Klungel OH; Heerdink ER; de Boer A
    Ann Pharmacother; 2006 Jan; 40(1):15-20. PubMed ID: 16303985
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Guidelines for pharmacists performing product selection.
    Am Pharm; 1990 Jul; NS30(7):40-1. PubMed ID: 2363394
    [No Abstract]   [Full Text] [Related]  

  • 35. A Systematic Review of Physicians' and Pharmacists' Perspectives on Generic Drug Use: What are the Global Challenges?
    Toverud EL; Hartmann K; Håkonsen H
    Appl Health Econ Health Policy; 2015 Aug; 13 Suppl 1(Suppl 1):S35-45. PubMed ID: 25963230
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Generic vs. brand name drugs--patients, pharmacists, physicians: caught in the middle.
    Felch WC
    Internist; 1979 May; 20(4):3-5. PubMed ID: 10242131
    [No Abstract]   [Full Text] [Related]  

  • 37. Prescribing patterns of antimicrobial agents in private practice in Umtata, Eastern Cape, South Africa.
    Katende-Kyenda N; Dambisya Y; Spring G
    Cent Afr J Med; 2004; 50(1-2):7-10. PubMed ID: 15490718
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Brand versus generic prescribing: a perspective of the Indian cardiologists' viewpoint.
    Bansinath M; Sequeira RP; Shukla VK; Mathur VS
    Int J Clin Pharmacol Ther Toxicol; 1984 Jun; 22(6):279-83. PubMed ID: 6746151
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intensive monitoring of new drugs based on first prescription signals from pharmacists: a pilot study.
    van Grootheest AC; Groote JK; de Jong-van den Berg LT
    Pharmacoepidemiol Drug Saf; 2003 Sep; 12(6):475-81. PubMed ID: 14513661
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Are brand-name and generic warfarin interchangeable? A survey of Ontario patients and physicians.
    Pereira JA; Holbrook AM; Dolovich L; Goldsmith C; Thabane L; Douketis JD; Crowther M; Bates SM; Ginsberg JS
    Can J Clin Pharmacol; 2005; 12(3):e229-39. PubMed ID: 16278495
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.